Adhesion GPCRs A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets

Scientist- Technology Tissue Culture Scientist/Tissue Culture Manager Postdoctoral Researcher Director - Targeted

Industry News Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting

GPR35 ligands that selectively modulate GPR35-transducer interactions and allow for mechanism-based therapies

understanding of class B1 GPCR biology but also opens new avenues for developing therapeutic agents that target

GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.

Confo Therapeutics Enters Into Research Collaboration For GPCR-Targeting Antibody Discovery With AbCellera

sessions: Utilizing new cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target

GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd

for its computational antibody drug discovery platform Antiverse identifies therapeutic antibodies targeting

Oncology and Immunology Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target

GPCR Partnered Events March 5 - 7, 2024 | 3rd GPCRs - Targeted Drug Discovery Summit Join us at the 3rd

significance in pain, addiction and depression opioid receptors represent important pharmacological targets

because, at that time, the neurexins, another family of adhesion molecules that also happened to be targeted

physiological importance in normal and pathological processes, so far no drugs have been approved that target

relevance of these PTMs in the chemokine receptor system which may ultimately allow for new precise targeting

important principles for drug treatment.[24–30] Black was particularly interested in developing drugs that targeted